This illustrated report has been adapted from a KFF Health News article, “Among Hurdles for Autoimmune Disease Patients: Diagnosis, Costs, Inattentive Care” by Andy Miller, with artwork by Oona Tempest.
Category: women’s health
Many Autoimmune Disease Patients Struggle With Diagnosis, Costs, Inattentive Care
Despite the prevalence of autoimmune conditions, like the thyroid disease Hashimoto’s, sometimes finding help can prove frustrating as well as expensive. There are often no definitive diagnostic tests, so patients may rack up big bills as they search for confirmation of their condition and for treatment options.
Backlash to Affirmative Action Hits Pioneering Maternal Health Program for Black Women
A San Francisco program offers a $1,000-a-month stipend for pregnant Black and Pacific Islander women, part of an effort to address severe racial disparities in maternal health. But conservative groups have sued to shut down the Abundant Birth Project, part of a national backlash against affirmative action in health care.
KFF Health News’ ‘What the Health?’: Congress Kicks the (Budget) Can Down the Road. Again.
Congress narrowly avoided a federal government shutdown for the second time in six weeks, as Democrats came to the rescue of divided House Republicans over annual spending bills that were supposed to be finished by Oct. 1. But the brinksmanship is likely to repeat itself early in 2024, when the next temporary spending patches expire. Meanwhile, a pair of investigations unveiled this week demonstrate how difficult it still is for seniors to get needed long-term and rehabilitation care. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News’ Julie Rovner to discuss these issues and more.
KFF Health News’ ‘What the Health?’: A Very Good Night for Abortion Rights Backers
Abortion rights backers won major victories in at least five states in the 2023 off-year elections Nov. 7, proving the staying power of abortion as a political issue in the wake of the Supreme Court’s 2022 decision overturning Roe v. Wade. Meanwhile, the National Institutes of Health finally has a new director, after Democrats temporarily blocked President Joe Biden’s nominee over a mostly unrelated fight about prescription drug prices. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Julie Appleby, who reported and wrote the latest “Bill of the Month” feature.